Nature Medicine
Bluesky
@natmed.nature.com
—Followers
—Following
0Posts Analyzed
Analyzed Posts (2)
Nature Medicine
@natmed.nature.comJul 30, 2026
This randomized phase 2b trial in adults with overweight or obesity shows that aleniglipron, an oral small molecule GLP1-RA, led to up to 11.3% weight loss vs placebo after 36 weeks of treatment. #clinicaltrial
Very strongView analysis
Nature Medicine
@natmed.nature.comJul 30, 2026
In the Phase 2 EMBRAZE study, participants receiving tirzepatide & apitegromab lost less lean-mass vs participants receiving tirzepatide & placebo. #clinicaltrials #incretins
Very strongView analysis